EEF1AKMT3 and neoplasm: Besides, the tumor mutation burden of LGG was markedly positively correlated with METTL21B, implying that patients with high expression level of METTL21B may be more likely to have favorable response to immunotherapy targeting immune checkpoints (Figure 8I).